The device is expected to improve outcomes for patients undergoing minimally invasive and open craniospinal procedures. Credit: Product Creation Studio/Newswire.

Medical device company PatchClamp Medtech, in partnership with Product Creation Studio, is set to develop a dural repair graft placement system for surgeries.

The system is designed to address the durotomy challenges during cranial and spinal surgeries by providing an immediate watertight seal for durotomies, which are perforations in the dura that can lead to serious complications.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

The device employs a unique graft-clasp mechanism that is specifically engineered to facilitate safe and immediate watertight sealing.

This potentially improves outcomes for patients undergoing minimally invasive and open craniospinal procedures.

PatchClamp Medtech co-founder Dr Marc Mayberg said: “Our device is not just a step forward in neurosurgical technology; it is a leap towards fundamentally changing how surgeons approach dural repairs. Achieving a watertight seal in a challenging surgical environment enhances patient safety and recovery, setting a new standard in surgical care.”

See Also:

Designed for ease of use, the dural repair graft system features a single-hand disposable applicator that allows surgeons to operate effectively in constrained spaces.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

To address the limitations of direct dural repair, the system integrates 3D-printed components with bioresorbable materials that are commercially available, demonstrating its proof of concept through rigorous in vitro and in vivo testing.

Product Creation Studio chief technology officer Scott Thielman said: “Working with the PatchClamp team has been inspiring. Their groundbreaking approach to surgical repair meshes perfectly with our mission to accelerate medical technology development that advances the field and improves patient outcomes.”

The device is yet to receive approval from the US Food and Drug Administration.